Cypress Capital »

Amgen shares owned by Cypress Capital

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Cypress Capital from 13F filings

Historical chart of Cypress Capital investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Cypress Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Cypress Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4M 8.4k 288.02
2023-09-30 $2.2M 8.3k 268.76

More positions owned by Cypress Capital

Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Abrdn Gold Etf Trust Physcl Gold Shs (SGOL)
Ishares Tr Tips Bd Etf (TIP)
Ishares Tr TRS FLT RT BD (TFLO)
Ishares Tr Hdg Msci Eafe (HEFA)
Proshares Tr S&p 500 Dv Arist (NOBL)
Apple (AAPL)
Cisco Systems (CSCO)
Broadcom (AVGO)

View all positions for Cypress Capital

Top funds holding Amgen

Vanguard Group
PRIMECAP Management Company
Charles Schwab Investment Management
Wells Fargo & Company
T. Rowe Price Associates
Royal Bank of Canada
Norges Bank Investment Management
Bank of New York Mellon
Legal & General Group
Bank of America Corporation
UBS Group
Goldman Sachs Group
Jpmorgan Chase & Co
Ubs Global Asset Management Americas
Barclays

View all funds holding Amgen